bms Accessing into CGT Field of Cell Gene Therapy

bms Accessing into CGT Field of Cell Gene Therapy Strategic Cooperate with Shenzhen Eurekabio

A grand signing ceremony was held between Wuhan bms Medicaltech Co.Ltd and Shenzhen Eurekabio Co.Ltd in the Medical Device Park, Wuhan East Lake High-Tech Optics Valley on August 2, 2022.

Mr. Ma Mo, Chairman of Eurekabio highly affirmed bms during the contact in the past one month, looking forward to the upcoming collaboration. Meanwhile Dr. He Jun, Chairman of bms, mentioned that bms has been deeply rooted in the blood transfusion field for a long time, the cooperation with Eurekabio is to treat tumor through handling of patient’s blood. Entering into the field of CGT is an expansion and extension of bms bushiness and technology.

Coincided with the occasion that the Capital Investment Fund Company made due diligence on bms, both parties signed a strategic cooperation agreement serving China, Hongkong and Macao. Moreover, both sides had a friendly and fruitful consultation to establish a education centre on cell therapy manufacturing techniques and product training   in central China Wuhan.